aTyr Pharma, Inc. announced it will present three posters at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, showcasing its lead candidate efzofitimod, currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results